Contract facts
UnrestrictedNo full NAICS 325412 intel page yet. Browse NAICS intelligence
IOFLUPANE - BRAND NAME OR EQUAL is a federal Unrestricted award for 244-Network Contract Office 4 (36C244) held by Jubilant Draximage Radiopharmacies, Inc. Estimated value $132K ($132K obligated). Current period of performance ends Jan 16, 2027. Last award drew 1 bidder. Place of performance: PHILADELPHIA PA.
Recompete timing
PublicCurrent PoP ends Jan 16, 2027 (107 days remaining). Agencies typically plan 12–18 months ahead — at 3.5 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C24426N0280? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies, Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C24426N0280?
36C24426N0280 (Ioflupane - BRAND NAME or EQUAL) is a 244-Network Contract Office 4 (36C244) award with a potential value of $132K, currently held by Jubilant Draximage Radiopharmacies, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C244-26-N-0280?
36C244-26-N-0280 is the dashed form of PIID 36C24426N0280 (Ioflupane - BRAND NAME or EQUAL), held by Jubilant Draximage Radiopharmacies, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C24426N0280?
244-Network Contract Office 4 (36C244) awarded 36C24426N0280 to Jubilant Draximage Radiopharmacies, Inc (potential $132K).
Who is the incumbent on 36C24426N0280?
Jubilant Draximage Radiopharmacies, Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Jan 16, 2027.
When does Jubilant Draximage Radiopharmacies, Inc’s 36C24426N0280 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 16, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C24426N0280? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Buy one Pursuit Analysis — $500Credits toward the Sprint Pack
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.